AI-Powered ECG Detecting Culprit Vessel Blood Flow Abnormality in ACS
NCT ID: NCT06528821
Last Updated: 2025-04-29
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
800 participants
OBSERVATIONAL
2024-12-10
2025-10-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
AI Algorithms in Prediction of ACS Based on Leukocyte Properties
NCT06384846
Artificial Intelligence System for Early Warning of Adverse Events in Acute Myocardial Infarction
NCT07139860
Artificial Intelligence Enhanced ECG to Detect Cardiac Amyloidosis
NCT05557162
Acute Myocardial Infarction Prediction Using Artificial Intelligence Applied to Electrocardiogram Images
NCT07163767
Automated Echocardiographic Detection of Coronary Artery Disease Using Artificial Intelligence Methods
NCT06314295
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Availability of a standard 12-lead ECG performed at invasive coronary angiogram before percutaneous coronary intervention (maximum within 15 min before vascular access).
* Age ≥18 years.
Exclusion Criteria
* Individuals presenting with chronic coronary syndrome (CCS) or stable angina symptoms.
* Individuals without symptoms suspicious for acute coronary syndromes.
* Individuals with contraindications for cardiac catheterization.
18 Years
85 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Powerful Medical
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Robert Herman, MD, PhD
Role: PRINCIPAL_INVESTIGATOR
Powerful Medical
Emanuele Barbato, MD, PhD
Role: STUDY_CHAIR
University of Roma La Sapienza
Jozef Bartunek, MD, PhD
Role: STUDY_CHAIR
Azorg Hospital, Aalst
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
LKH Hochsteiermark, Standort Bruck
Bruck an der Mur, , Austria
LKH II Standort West
Graz, , Austria
Medical University of Graz
Graz, , Austria
OLV Aalst
Aalst, , Belgium
AZ Sint Jan
Bruges, , Belgium
Jessa Ziekenhuis
Hasselt, , Belgium
University Hospital D'Annunzio Chieti
Chieti, , Italy
San Pietro Hospital
Rome, , Italy
Sant´Andrea Hospital
Rome, , Italy
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Gert Klug, Prim. Dr.
Role: primary
Martin Genger, Prim. Dr.
Role: primary
Gabor Toth, MD
Role: primary
Adriaan Wilgenhof, MD
Role: primary
Ian Buysschaert, MD
Role: primary
Pascal Vranckx, MD
Role: primary
Fabrizio Ricci, MD, PhD
Role: primary
Dario Bertolone, MD
Role: primary
Marta Belmonte, MD
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
AI-ECG-TIMI_v1
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.